ALLMedicine™ Systemic Lupus Erythematosus Center
Research & Reviews 10,076 results
https://doi.org/10.1177/03946320221101287
International Journal of Immunopathology and Pharmacology; Liu H, Li Q et. al.
May 21st, 2022 - Background: Systemic lupus erythematosus (SLE) commonly occurs in premenopausal women and is associated with elevated estrogen levels. Patients with SLE may have abnormal serum triglyceride (TG) levels, and lipid reportedly promotes kidney damage ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113863
Journal of Immunology Research; Luo S, Wu R et. al.
May 21st, 2022 - Interferon-inducible 44 like (IFI44L) is a newly discovered interferon-induced gene and has been reported to overexpress in systemic lupus erythematosus (SLE). However, little is known about the mechanism and function of IFI44L overexpression in S...
https://clinicaltrials.gov/ct2/show/NCT04895696
May 20th, 2022 - The purpose of this study is to evaluate the effectiveness, safety and tolerability of Afimetoran in participants with active Systemic Lupus Erythematosus (SLE).
https://clinicaltrials.gov/ct2/show/NCT00001372
May 20th, 2022 - This research protocol will evaluate subjects with systemic lupus erythematosus (SLE) and their relatives to study the pathogenesis and natural history of the disease and the mechanisms leading to enhanced organ damage. Patients will be evaluated ...
https://clinicaltrials.gov/ct2/show/NCT04233164
May 20th, 2022 - Systemic lupus erythematosus (SLE) is a systemic autoimmune syndrome that causes pervasive immune dysregulation in all cells of the innate and adaptive immune system. Most patients with SLE require glucocorticoid treatment at some point of the dis...
Guidelines 11 results
https://doi.org/10.1016/j.earlhumdev.2019.104871
Early Human Development; James WH, Grech V
Sep 8th, 2019 - There is good evidence that there are significantly low sex ratios (proportions male) in the offspring of patients with some immune diseases e.g. systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). There is also strong evidence that ...
https://doi.org/10.1136/annrheumdis-2019-215089
Annals of the Rheumatic Diseases; Fanouriakis A, Kostopoulou M et. al.
Mar 31st, 2019 - Our objective was to update the EULAR recommendations for the management of systemic lupus erythematosus (SLE), based on emerging new evidence. We performed a systematic literature review (01/2007-12/2017), followed by modified Delphi method, to f...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225798
Annals of the Rheumatic Diseases; Pons-Estel BA, Bonfa E et. al.
Jul 27th, 2018 - Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune disease, represents a significant challenge for both diagnosis and treatment. Patients with SLE in Latin America face special problems that should be considered when therap...
https://doi.org/10.1093/rheumatology/kex291
Rheumatology (Oxford, England); Gordon C, Amissah-Arthur MB et. al.
Oct 14th, 2017 - The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary.|2017|Gordon C,Amissah-Arthur MB,Gayed M,Brown S,Bruce IN,|diagnosis,immunology,therapy,
https://doi.org/10.1093/rheumatology/kex286
Rheumatology (Oxford, England); Gordon C, Amissah-Arthur MB et. al.
Oct 14th, 2017 - The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults.|2017|Gordon C,Amissah-Arthur MB,Gayed M,Brown S,Bruce IN,|diagnosis,therapy,standards,standards,
Drugs 343 results see all →
Clinicaltrials.gov 249 results
https://clinicaltrials.gov/ct2/show/NCT04895696
May 20th, 2022 - The purpose of this study is to evaluate the effectiveness, safety and tolerability of Afimetoran in participants with active Systemic Lupus Erythematosus (SLE).
https://clinicaltrials.gov/ct2/show/NCT00001372
May 20th, 2022 - This research protocol will evaluate subjects with systemic lupus erythematosus (SLE) and their relatives to study the pathogenesis and natural history of the disease and the mechanisms leading to enhanced organ damage. Patients will be evaluated ...
https://clinicaltrials.gov/ct2/show/NCT04233164
May 20th, 2022 - Systemic lupus erythematosus (SLE) is a systemic autoimmune syndrome that causes pervasive immune dysregulation in all cells of the innate and adaptive immune system. Most patients with SLE require glucocorticoid treatment at some point of the dis...
https://clinicaltrials.gov/ct2/show/NCT04098055
May 19th, 2022 - Demonstrate that custom-made insoles improve painful symptomatology, health and foot function in subjects with SLE and podiatric involvement.
https://clinicaltrials.gov/ct2/show/NCT05013463
May 18th, 2022 - In patients with SPMS, there is ongoing slow and continuous loss of nerve cells, which causes damage to the brain and spinal cord. This ultimately becomes noticeable as slowly and continuously worsening disability. While the cause of this ongoing ...
News 948 results
https://www.mdedge.com/rheumatology/article/254271/lupus-connective-tissue-diseases/expanded-treatment-options-lupus
Joan Merrill, MD
May 6th, 2022 - Lupus nephritis (LN) affects approximately 25%-60% of patients with systemic lupus erythematosus. Currently, guideline-directed therapy recommends a combination of steroids plus either mycophenolate mofetil or cyclophosphamide.
https://www.medscape.com/viewarticle/973212
Apr 29th, 2022 - Women with systemic lupus erythematosus (SLE) experience worse outcomes after an acute stroke than does the general population, but men with SLE do not, according to an analysis of the U.S. National Inpatient Sample presented at the annual meeting...
https://www.medscape.com/viewarticle/970425
Mar 17th, 2022 - (Reuters Health) - Up to 54% of patients with systemic lupus erythematosus (SLE) were helped by daily therapy with Bristol Myers Squibb's experimental drug iberdomide, but only at the highest dose tested, researchers report in Thursday's New Engla...
https://www.medpagetoday.com/rheumatology/lupus/97690
Mar 16th, 2022 - What could be the first oral medication specific for systemic lupus erythematosus (SLE) was more effective than placebo in a randomized phase II trial, though the results were something less than a home run. With 288 patients assigned to three dos...
https://www.medscape.com/viewarticle/969350
Feb 28th, 2022 - Disparities in healthcare exist in every specialty. In rheumatology, health disparities look like lack of access to care and lack of education on the part of rheumatologists and their patients, according to a speaker at the 2022 Rheumatology Winte...